U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07680907) titled 'A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)' on June 26.
Brief Summary: This study aims to better understand people who have advanced or metastatic non-small cell lung cancer (NSCLC) with an EGFR mutation. NSCLC is an advanced stage cancer of the lung, occurring due to mutations (changes) in the EGFR gene. The study will assess the participant demographic background (that is age, gender etc.), the treatments they receive, how well those treatments work, and their health outcomes.
Study Start Date: July 30
Study Type: OBSERVATIONAL
Condition:
Car...